The glycogen-loading hypothesis behind a teaspoon of honey before bed, and what the evidence does and does not support.
A teaspoon of honey before bed is a long-standing practice with a plausible mechanism — replenishing liver glycogen to reduce overnight cortisol-driven waking. The mechanism is reasonable, the clinical sleep evidence is limited, and very little of it is Manuka-specific. A reasonable habit, not a treatment for insomnia.
A teaspoon of honey before bed is one of those practices that travels under both folk wisdom and physiology textbook. The folk version is older than any laboratory work; the textbook version draws on the basic biology of overnight fuel metabolism, which is genuinely interesting and partially explains why the practice persists.
During sleep, the liver continues to release glucose into the bloodstream to maintain normal levels for the brain and other tissues. The liver does this by drawing on its glycogen stores, which were deposited from the day's food. As those stores deplete towards the end of the night, the body's ordinary stress-axis machinery kicks in: cortisol and adrenaline rise, mobilising fuel from other sources. That hormonal shift is part of why people often wake in the early hours, particularly if the previous evening's intake was modest. The argument for bedtime carbohydrate — and for honey specifically as a vehicle — is that a small dose of mixed fructose and glucose, taken just before sleep, refills liver glycogen efficiently and reduces the magnitude of that overnight stress-axis rise.
Whether the practice meaningfully improves measured sleep is a separate question, and the evidence base specific to that question is small.
The mechanistic argument is straightforward and not Manuka-specific.
Honey contains roughly equal proportions of fructose and glucose — typically a slight fructose lead — which makes it well-suited to liver glycogen replenishment in particular. Fructose is preferentially taken up by the liver and converted into glycogen, while glucose contributes both to liver glycogen and to maintaining circulating blood sugar in the short term after ingestion. The combination is what makes honey a more efficient glycogen-loading vehicle, gram for gram, than table sugar (sucrose) or pure glucose.
The bedtime application of that mechanism — sometimes called the "honey-before-bed" or "Honey Diet" hypothesis — proposes that topping up liver glycogen reduces the depth of the overnight hormonal counter-regulation, which in turn reduces awakenings and improves the subjective quality of sleep. As mechanistic stories go, this is reasonable: the liver-glycogen and overnight-cortisol pieces are well established; the bridge between them and a measurable change in sleep architecture is the part that has not been firmly nailed down clinically.
The arguments for Manuka honey specifically in this context are weak. The fructose-glucose ratio of Manuka is not meaningfully different from other honeys, and the antibacterial properties that make Manuka distinctive elsewhere are not the relevant mechanism here. People who use Manuka before bed usually do so because they are using it during the day for other reasons; for the sleep argument alone, ordinary honey would do the same job.
The clinical evidence on bedtime carbohydrate and sleep, taken broadly, is limited and mixed. Small studies have suggested modest improvements in sleep onset and continuity with bedtime carbohydrate in some populations; other work has been neutral or contradictory. The variability across study designs, populations, and outcome measures is large, and there is no large randomised trial that establishes a robust effect.
For honey specifically, most published clinical work on sleep relates to cough-associated sleep disturbance in upper respiratory tract infections — the relevant evidence sits in the upper respiratory literature (Abuelgasim et al., 2020) rather than in primary insomnia trials. The interpretation is "honey reduces nocturnal cough, which improves sleep in a sick person", not "honey improves sleep in a healthy adult".
For Manuka honey specifically and sleep outcomes, the evidence base is essentially absent at the level of randomised controlled trials. Anecdotal and traditional support is widespread; controlled clinical evidence is not.
What the evidence does not support is language like "treats insomnia", "increases deep sleep", or "fixes night-time waking". The defensible claims are: a plausible mechanism through liver-glycogen replenishment; a long-standing traditional and observational practice; and modest, mixed clinical evidence for bedtime carbohydrate in sleep, very little of it Manuka-specific.
The pattern that matches both the tradition and the mechanism is a teaspoon (around 5–7g) of honey in the half-hour before bed, taken neat or stirred into a warm drink. Larger amounts are not better; the underlying mechanism is about a modest top-up to liver glycogen, not a sugar load. For everyday use, a lower- or mid-tier grade — UMF 5+, UMF 10+, or UMF 15+ — is the typical choice, and there is no evidence that higher grades produce better sleep outcomes. The how-to-use-manuka primer covers common patterns.
For people who train hard and are using honey for recovery as well as sleep, the energy and training page covers post-exercise patterns; for people whose sleep is disturbed by an active sore throat or cough, the sore-throat page covers symptom-relief patterns directly relevant to that situation.
If sleep is consistently poor — difficulty falling asleep, frequent waking, severe daytime sleepiness, loud snoring with witnessed apnoeas, or restless legs — that is a clinical question, not a honey question. A proper sleep assessment, with attention to underlying conditions and to first-line treatments such as CBT-I, is the right path. Manuka honey is reasonable supporting practice for ordinary nights; it is not a sleep medication, and it is not a substitute for clinical assessment when sleep is genuinely disordered.
Honey of any kind — including Manuka honey — must not be given to infants under 12 months old, due to the risk of infant botulism. People with bee, pollen, or honey allergies should avoid Manuka honey.
People managing diabetes should be particularly cautious about taking sugar at bedtime, when glucose monitoring is less frequent and overnight hypoglycaemia or hyperglycaemia carry their own risks. Insulin-treated diabetes, in particular, requires individualised advice from the treating team about any consistent bedtime carbohydrate.
Persistent insomnia, severe daytime sleepiness, loud snoring with witnessed apnoeas, restless legs, or sleep that is not restorative despite adequate time in bed are clinical questions, not food-and-supplement questions. They warrant assessment for sleep disorders such as obstructive sleep apnoea, periodic limb movement disorder, or insomnia disorder, rather than escalation of bedtime honey. Manuka honey is a food, not a sedative or a sleep medication.